








































Reduced expression of the Indy (Acronym for ‘I am Not 
Dead, Yet’) gene in Drosophila melanogaster promotes 
longevity in most studies [1-5]. The underlying 
mechanisms recapitulate multiple characteristics of 
caloric restriction, i.e. reduced in body fat,  insulin like 
proteins [4], and increased mitochondrial biogenesis 
[1,6], along with the activation of FOXO and the co-
transcriptional regulator PGC-1α [1, 2, 4, 7]. 
Interestingly, food intake in the long lived, Indy mutant 
flies is not reduced. Knocking down the Indy homolog 
CeNAC2 in C. elegans also promotes a moderate 
increase in lifespan in one study [8],  while another study 
 
 







































failed to observe the phenotype [9]. Whether or not the 
knockdown of CeNAC2 really promotes longevity and 
by which mechanism remains unclear. 
 
In mammals, deletion of the homolog of Indy (mIndy, 
Slc13A5), protects mice from high fat diet and aging 
induced obesity, insulin resistance and nonalcoholic 
fatty liver disease (NAFLD), at least in part through the 
activation of the intracellular energy sensor AMP-
activated protein kinase A (AMPK) [6]. Life span in 
these mice has not yet been studied.  
 
The mIndy encoded protein mINDY is part of the 
SLC13 protein family, consisting of Na-carboxylate and 

























used  to  reduce  expression of  Indy/CeNAC2. Mean  life  span was  assessed  in  four  independent experiments, as well  as
whole  body  fat  content  and  AMPK  activation.  Moreover,  the  effect  of  Indy/CeNAC2  knockdown  in  C.  elegans  with
inactivating variants of AMPK (TG38) was studied. Knockdown of Indy/CeNAC2 increased life span by 22±3 % compared to
control siRNA  treated C. elegans,  together with a decrease  in whole body  fat content by ~50%.  Indy/CeNAC2 reduction
also increased the activation of the intracellular energy sensor AMPK/aak2. In worms without functional AMPK/aak2, life
span  was  not  extended  when  Indy/CeNAC2  was  reduced.  Inhibition  of  glycolysis  with  deoxyglucose,  an  intervention
known to  increase AMPK/aak2 activity and  life span, did not promote  longevity when Indy/CeNAC2 was knocked down.
Together,  these data  indicate  that  reducing  the expression of  Indy/CeNAC2  increases  life  span  in C. elegans,   an effect
mediated at least in part by AMPK/aak2.  
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Na-sulfate cotransporters in vertebrates, invertebrates, 
plants, and bacteria [10, 11]. mINDY mediates the 
cotransport of citrate, succinate, and several other 
dicarboxylates across the plasma membrane together 
with sodium in an electrogenic manner [12]. The amino 
acid sequence of the N-terminal sodium and the 
carboxy-binding motif is highly conserved between 
many species, from bacteria to C. elegans to human 
[13]. Therefore, C. elegans might serve as a model 
entity for higher organisms. 
 
The C.elegans Indy homolog CeNAC2 is expressed 
mostly in tissues that function as sites of nutrient 
absorption and fat storage [4, 12, 14]. Indy/CeNAC2 is 
located on the plasma membrane and transports TCA 
cycle intermediates, which are used to generate 
biochemical energy in the form of ATP. A tight 
regulation of net energy flux is a fundamental 
requirement of living organisms. Alteration of these 
processes can lead to profound changes in the ability of 
cells to cope with sudden changes in energy demand and 
can result in premature death. Therefore, cells possess 
several mechanisms to adjust and tune in energy demand 
and synthesis. One kinase controlling these mechanisms 
is AMP activated protein kinase (AMPK) [15, 16]. 
AMPK is activated in states of low energy supply 
through AMP, and it is inhibited in states of high energy 
abundance by ATP. Upon activation, AMPK increases 
mitochondrial biogenesis and shifts energy generation 
from glycolysis to the oxidation of fat, yielding higher 
























homolog aak2 mediates the life extending effect of 
glucose restriction in C. elegans [15, 17,20]. 
 
Here, we aimed at clarifying whether or not knocking 
down the C. elegans Indy homolog CeNAC2 increases 
life span similar to the studies in D. melanogaster. We 
hypothesized that longevity in Indy/CeNAC2 reduced 





Effect of Indy/CeNAC2 knockdown on life span  
 
Knockdown of Indy/CeNAC2 by feeding wildtype N2 
worms with bacteria expressing Indy/CeNAC2-specific 
siRNA caused a significant increase in average life span 
of the organism (Fig. 1A). Individual data from 4 
independent experiments are given in Table 1a-d. Mean 
life span of the worms fed on bacteria harboring 
Indy/CeNAC2-specific siRNA was 19.3±0.52 days; 
mean life span of the worms fed on bacteria harboring 
the empty vector L4400 was 15.8 ±0.29 days (Tab.1b). 
The increase in average life span induced by 
Indy/CeNAC2 knockdown was +22% (Log Rank 
p≤0.001). A partial loss of function daf-2 mutant strain 
(CB1370) was included as a positive control in the 
experiments and showed the documented life span 
extension (Table 1a-d) [18]. Thus, our studies confirm a 
life span extending effect of reduced Indy/CeNAC2 


























Table 1a. Life-span No.1 











N2 / empty vector control 16.4 ± 0.28 60  0.004  ≤0.001 
N2 / INDY/CeNAC2 17.2 ± 0.36 60    ≤0.001 
TG38 / empty vector control 13.5 ± 0.26 60   0.119 ≤0.001 
TG38 / INDY/CeNAC2 14.2 ± 0.29 60    ≤0.001 
CB1370 / empty vector control 28.1 ± 1.32 60         
 
 
Table 1b. Life-span No.2 











N2 / empty vector control 15.8 ± 0.29 60  ≤0.001  ≤0.001 
N2 / INDY/CeNAC2 19.3 ± 0.52 60    ≤0.001 
TG38 / empty vector control 14.1 ± 0.21 60   0.027 ≤0.001 
TG38 / INDY/CeNAC2 14.7 ± 0.26 60    ≤0.001 
CB1370 / empty vector control 28.5 ± 1.25 60         
 
  

































Effect of Indy/CeNAC2 knockdown on body fat 
content 
 
In order to test whether or not reduction of 
Indy/CeNAC2 in C.elegans also shares characteristics 
of caloric restriction, whole body fat stores were 
analyzed by phase contrast microscopy using the azo 
compound Oil Red O to stain triglycerides. The 
intensity (area by pixel) of Oil Red O staining of worms 
fed on bacteria harboring Indy/CeNAC2-specific 
siRNA was ~ 50% lower compared to control worms 
that were fed on bacteria harboring empty vector L4400 
(Indy/CeNAC2-specific siRNA: 5.4e+006±76988, 
control L4400:  1.016e+007±1.127e+006, p=0.006 
Wilcoxon test) (Fig. 1B-D). 
 
Knockdown of CeNAC2 leads to the activation of 
AMPK 
 
Given the life span extending effect of Indy/CeNAC2 
knockdown together with a reduction in body fat 


































molecular mechanism. In mice, deletion of mIndy 
reduced the hepatocellular ATP/ADP ratio and 
activated hepatic AMPK [6, 19]. The C. elegans 
AMPK homolog aak2, has been shown to mediate the 
life span extending effect of various short-term 
stressors [17] including glucose restriction [20]. 
Phosphorylation of AMPK/aak2 at threonine 172 is 
widely used as a surrogate marker of activity of this 
kinase. Therefore, the phosphorylation of aak2 in 
worms fed on bacteria harboring Indy/CeNAC2 
siRNA was analyzed. Western blot analysis of cell 
extracts was carried out using an antibody against 
phospho-Thr172 of the human AMPK. AMPK/aak2 
was markedly phosphorylated in worms with reduced 
Indy/CeNAC2. A lower state of phosphorylation of 
AMPK/aak2 was observed for wildtype N2 under 
control conditions, fed with bacteria harboring the 
empty vector L4400. Blotted extracts of worms with a 
deletion in the aak2 gene (TG38 aak-2(gt33)), 
including the phosphorylation site, showed no signal 
for phosphorylated AMPK/aak2 (Fig. 1E).  
 
Table 1c. Life-span No.3 











N2 / empty vector control 15.1 ± 0.28 60  ≤0.001  ≤0.001 
N2 / INDY/CeNAC2 17.8 ± 0.39 60    ≤0.001 
TG38 / empty vector control 15.1 ± 0.26 60   0.120 ≤0.001 
TG38 / INDY/CeNAC2 17.8 ± 0.29 60    ≤0.001 
CB1370 / empty vector control 15.1 ± 0.28 60   ≤0.001 
 
 
Table 1d. Life-span No.4 











N2 / empty vector control 14.1 ± 0.27 60  ≤0.001  ≤0.001 
N2 / INDY/CeNAC2 15.9 ± 0.27 60    ≤0.001 
TG38 / empty vector control 15.1 ± 0.46 60   0.606 ≤0.001 
TG38 / INDY/CeNAC2 14.8 ± 0.42 60    ≤0.001 























































































































Figure 1.  (A) Representative survival curves  for N2  (WT),  fed with E. coli GC363 harboring  the empty vector L4400  (empty vector





elegans strains  (N2, TG) and  fasted mouse  liver  lysate  (C) as positive control  for phosphorylation  (activation) of AMPK/ aak‐2 after
knockdown of INDY/CeNAC2 (N2/I). Down regulation of INDY/CeNAC2  leads to activation of AMPK / aak‐2 compared to control fed
wildtype N2. Negative  control TG38  (TG) with missing phosphorylation  site  for AMPK‐Thr172  shows no activation when  fed with
empty vector control neither when treated with RNAi against INDY/CeNAC2 (G/i). Control (c) = liver lysates from fasted mice.  
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Effect of glucose restriction on life span in 
Indy/CeNAC2 knockdown 
 
AMPK/aak2 mediates the life span extending effect of 
glucose restriction in C. elegans [20]. Since 
AMPK/aak2 was activated in Indy/CeNAC2 RNAi 
treated worms, and Indy/ceNAC2 encodes a transporter 
for citrate, a metabolite interfering with glycolysis [11, 
21], altered rates of substrate flux through glycolysis 
might be a unifying principle to couple life span 
extension via AMPK to the knockdown of 
Indy/CeNAC2. Glycolysis can be inhibited by 2-Deoxy-
D-glucose (DOG), a molecule which competitively 









































glucose at the phosphoglucokinase level. This is due to 
the 2-hydroxyl group replaced by hydrogen, rendering 
DOG incompatible for further glycolysis, while 
metabolism of other nutrients remains unaffected. 
Therefore, we tested whether or not DOG administration 
is still effective in increasing life span in Indy/ceNAC2 
knockdown C. elegans. Exposure of 5mM DOG to the 
nematodes caused a significant increase in average life 
span of the organism by 20±1.3% (Log Rank p≤0.001). 
Exposure of DOG to nematodes with simultaneous 
knockdown of the Indy homolog CeNAC2 did not show 
any further life span extension (Log Rank p=0.135) 
(Fig.2A, Tab.2a-c), suggesting that both interventions 










































Figure  2.  (A)  Survival  curves  for  TG38 AMPK/akk‐2(gt33),  fed with  E.  coli GC363 harboring  the
empty vector L4400 (empty vector control) versus E. coli GC363 harboring INDY/CeNAC2‐specific
siRNA and CB1370 daf‐2(e1370)  fed with empty vector control.  (B) Survival curves  for N2  (WT),













































Role of AMPK/aak2 in the life span extending effect 
of Indy/CeNAC2  
 
In order to determine whether or not the life span 
extending effect of the reduction of Indy/CeNAC2 
depends on AMPK/aak2, life span studies were repeated 
in C. elegans with an inactivating mutation of 
AMPK/aak2, TG38 aak-2(gt33). In these TG38 aak-
2(gt33) worms, RNAi-mediated knock down of 
Indy/CeNAC2 did not increase average life span, while 
we continued to observe the life span extending effect 
in the N2 wild type (Fig.2A and Tab.1a-d). Mean life 
span of TG38 aak-2(gt33)/empty vector control did not 
differ from TG38 aak-2(gt33)/ Indy/CeNAC2 in all 









































a positive control for life span extension, showed the 
expected increase in life span in all experiments 
(Tab.1a-d). To confirm that the mutation in 
AMPK/aak2 did not by itself alter the expression of 
Indy/CeNAC2, expression levels were determined by 
qPCR. Expression levels of Indy/CeNAC2 in TG38 
(aak-2(gt33)) Indy/CeNAC2 siRNA treated worms were 
lowered by 58% (p=0.05) compared to TG38 aak-




Our studies show that knockdown of Indy/CeNAC2 in 
C. elegans leads to a significant increase in life span. 
AMPK/aak2 was activated in CeNAC2 reduced C. 
Table 2. Mean life spans when treated with deoxyglucose (DOG)
Table 2a. Life-span No.1               







DOG - / empty vector control 9.9 ± 0.44 60 0.010 
DOG - / INDY/CeNAC2 11.8 ± 0.57 60 0.841 
DOG + / INDY/CeNAC2 11.6 ± 0.51 60 
DOG + / empty vector control 13.4 ± 0.73 60 0.080 
     
 
Table 2b. Life-span No.2               







DOG - / empty vector control 10.3 ± 0.47 60 0.007 
DOG - / INDY/CeNAC2 12.2 ± 0.62 60 0.432 
DOG + / INDY/CeNAC2 11.7 ± 0.50 60 
DOG + / empty vector control 12.9 ± 0.66 60 0.217 
     
 
Table 2c. Life-span No.3               







DOG - / empty vector control 10.3 ± 0.48 60 0.002 
DOG - / INDY/CeNAC2 12.7 ± 0.66 60 0.119 
DOG + / INDY/CeNAC2 11.6 ± 0.47 60 
DOG + / empty vector control 12.9 ± 0.69 60 0.109 
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elegans. Moreover, in worms with inactivated AMPK, 
knockdown of CeNAC2 was not able to extend life 
span. Thus, our data suggest that the life span extending 
effect of knockdown of Indy/CeNAC2 is mediated via 
AMPK, at least in part.  
 
A previous study did not observe a life span extending 
effect of Indy/CeNAC2 knockdown in C. elegans nor a 
life span increase with Indy knockdown in D. 
melanogaster [9]. Subsequent studies in D. 
melanogaster have resolved this discrepancy in flies by 
demonstrating that knockdown of Indy in flies is 
mediated by the induction of a calorie restriction-like 
state [4], as it is in mice [6]. A possible explanation 
might be that the two studies used different diets, with 
the study that did not observe a life span extension used 
a diet in flies that resembled more a low calorie diet [4, 
9, 22]. In this scenario, it is possible that the 
knockdown of Indy does not extend life span any 
further. 
 
In the study presented here, E.coli GC363 harboring the 
empty vector L4400 or the vector with the CeNAC2-
specific siRNA was used. Using this regular, commonly 
used food [23], we observed a life span extending effect 
with the knock down of Indy/CeNAC2 in C. elegans for 
mean, median and maximum life span (see 
supplemental data Table S3 and S5). Together with life 
span extension, Indy/CeNAC2 Knockdown also 
resulted in reduced whole body fat stores in our worms. 
This finding is in line with observations in D. 
melanogaster [4], C. elegans [8] and mice [6]. The 
reduction in body fat might be mediated via multiple 
mechanisms. First, the functional role of Indy/CeNAC2 
is to import citrate as well as several dicarboxylates into 
the cytosol as substrates for several metabolic processes 
[8]. For example, citrate is the main carbon source of 
fatty acid and cholesterol synthesis, and it acts as an 
allosteric activator of acetyl-CoA carboxylase (ACC) 
[11]. Moreover, cytosolic citrate furnishes NADPH 
generation via malic enzyme for lipogenesis [24]. 
Overexpression of mammalian Indy homolog in a 
HepG2 cell line resulted in an increase in intracellular 
fatty acid and sterol synthesis in our previous studies 
[25]. In line with this notion, enhancing the activity of 
citrate transport by mINDY in HepG2 cells has been 
shown to enhance citrate induced lipid synthesis [25, 
26], while knocking down mINDY in hepatocytes 
leads to a reduction in hepatocyte lipid content [6, 27]. 
It is possible that reducing the import of citrate by 
knocking down Indy/CeNAC2 reduces lipid synthesis 
directly by reducing citrate as a C-donor for fatty acid 
synthesis as well as an allosteric activator for lipid 
synthesis [27]. 
Moreover, we observed that reducing Indy/CeNAC2 
expression is associated with the activation of the 
intracellular energy sensor AMPK/aak2. When reducing 
Indy/CeNAC2 expression in AMPK/aak2 mutated C. 
elegans TG38 aak-2(gt33), which do not possess the 
ability to phosphorylate, and thus, activate AMPK, the 
life span extending effect of the Indy/CeNAC2 KD was 
not observed any longer.  
 
AMPK has previously been shown to mediate longevity 
in C. elegans when glucose is restricted as a nutritional 
substrate [20]. In this case, AMPK is activated via 
AMP. Moreover, AMPK has also been put into context 
to mediate the longevity effect of SIRT1 and metformin 
in C. elegans and mice [15,16,28]. Moreover, 
metformin might activate AMPK via inhibition of 
complex 1 of the respiratory chain, reducing ATP 
generation and increasing the AMP/ATP ratio. Other 
mechanisms contribute [29]. The inability to increase 
lipid oxidation in aging rats has been attributed to 
reduced activation of AMPK [30]. Finally, in mice with 
deleted mINDY, the ATP/AMP ratio is shifted towards 
AMP, and ATP levels are largely reduced [6, 31]. 
Consecutively, AMPK is activated when INDY is 
knocked out in mice. Collectively, these data provide a 
rationale for the molecular mechanisms mediating 
longevity when Indy/CeNAC is reduced. 
 
In our studies, reducing glucose availability through 
DOG did not enhance life span any further in 
Indy/CeNAC2 knock down, as shown for mean, median 
and maximum life span (see supplemental data Table S4 
and S6). These data further strengthen the role of 
AMPK in mediating the life span extending effect of 
Indy/CeNAC2 reduction, since inhibition of glycolysis 
using DOG in C. elegans has been shown to lead to an 
extended life span by activating AMPK [20]. Findings 
from Neretti and colleagues suggested that when INDY 
is reduced, a decreased flux of electrons through the 
electron transport chain associated with an upregulation 
of mitochondrial biogenesis combine to result in an 
overall decrease of reactive oxygen species and 
maintenance of normal cellular ATP levels [1]. Clearly, 
a thorough analysis of the metabolic pathways that are 
altered by the deletion and/or reduction of 
Indy/CeNAC2 are needed to better understand how 
AMPK/aak2 might be activated.  
 
In summary, knockdown of Indy/CeNAC2 in C. 
elegans extends life span along with the activation of 
the intracellular energy sensor AMPK. Our data support 
the hypothesis that AMPK is indispensable for 
Indy/CeNAC2 to mediate longevity and provide a 
rationale for the molecular mechanisms mediating 
longevity when Indy/CeNAC2 is reduced. Together, 
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these data suggest that reducing the expression or 
activity of the mammalian homolog of the tri- and 
dicarboxylic acid transporter Indy/CeNAC2 might be an 
attractive target to promote healthy aging by activating 




Strains and culture conditions. C. elegans strains Wild-
type N2, TG38 aak-2(gt33) and E.coli OP50 and 
GC363 were obtained from the Caenorhabditis 
Genetics Center (Minneapolis, MN). The gt33 allele has 
a 606-bp deletion. Wild-type N2 and aak-2 mutant 
worms were maintained at 22°C on Nematode Growth 
Medium (NGM) plates seeded with E. coli OP50 using 
standard methods [32] except for experiments where 
other is specified.  
 
Bacterially-mediated RNAi. Genetically modified 
bacteria strain (E. coli HT115 ) for CeINDY was 
retrieved from Source BioScience. Carrying the L4400 
vector, which contains convergent T7 polymerase 
promoters separated by a multicloning site. E. coli 
GC363 carry the empty L4400 vector and are 
considered as the control. Control and siRNA 
expressing E.coli strains were grown over night on LB 
Agar at 37°C containing 100 µg/ml ampicillin and 12.5 
µg tetracyclin. A single colony was picket and 
transferred into LB-Media and cultivated over night for 
a starter culture. Preceding every experiment for 
bacterial-mediated RNAi, a fresh culture was grown for 
6h in LB-Media from an aliquot of the starter culture. 4-
7 days ahead of every experiment the according NGM 
plates were prepared containing 100 µg/ml ampicillin 
(Roth) and 1mM Isopropyl-β-D-thiogalactopyranoside 
(IPTG, Sigma) as well as 0.1 mg/ml 5-fluoro-2'-
deoxyuridine (FUDR, Sigma) if needed.  
 
Life span assays. Worms were cultured at 20°C on 
Nematode Growth Medium (NGM) plates seeded with E. 
coli OP50 using standard methods. Prior to the 
experiments worms were synchronized via 20% Alkaline 
Hypochlorite Solution using standard protocol [32], eggs 
were transferred to new plates seeded with OP50. At the 
L4 (t=0) moult, animals were transferred to plates 
containing ampicillin, FUDR and IPTG. RNAi 
expressing bacteria, were received as sequence verified 
strains by BioSource (Nottingham, GB). RNAi mediated 
knockdown of CeNAC2 in N2 was conducted as 
described by Fei et al. 2003 with significant down 
regulation of gene expression. As mentioned above 
seeded with RNAi expressing bacteria or control bacteria 
(empty vector control). Animals were transferred to new 
plates every second day and counted. Animals were 
judged dead when they did not move after repeated 
prodding with a pick. Animals that crawled off the plates 
were not included in the analysis (Kaplan Meyer). Assays 
were repeated independently four times for validation. 
Plates for life span assay with DOG were prepared from 
the same bath of NGM agar. The respective chemical 
was added to a final concentration of 5 mM from a sterile 
0.5 M stock solution for DOG. DOG treatment lasted for 
seven days after larvae reached the L4 moult. Assay was 
conducted until all worms were either censored or 
counted as dead as described above.  
 
Expression. Parallel to life span assays nematodes were 
cultured on plates containing ampicillin, FUDR and 
IPTG as mentioned above for 5 days, regularly fed with 
siRNA expressing bacteria. After 5 days worms were 
washed off plates with M9-Buffer and shortly 
centrifuged. Supernatant was removed and 500 µl 
TRIZOL (Life Technologies) was added to the worm 
pellet. For lysis of worms a Speed Mill (Analytik Jena) 
was used. Samples were centrifuged for 5 min at full 
speed, supernatant was transferred into a new tube and 
100 µl was added per 500 µl of supernatant volume. 
Followed by an incubation for 2 min on ice, the samples 
were centrifuged for 15min at 4°C (12000xg). The polar 
phase was removed and the nucleic acids were 
precipitated via isopropyl and washed with ethanol 
(70%). RNA was resuspended in nuclease free water. 
Residues of DNA were digested using DNase I, Rnase-
free (Thermo Scientific), for cDNA synthesis RevertAid 
First Strand cDNA Synthesis Kit was used. For 
detection SYBR Green and 7300 Real Time RCE 
System by Apllied Biosystems was used. Once 
knockdown was established it was checked periodically. 
 
Western blot analysis. Synchronized Wild-type N2 and 
aak-2(gt33) eggs were transferred to NGM plates with 
GC363 as the main food source. At 22°C eggs were 
allowed to hatch und larvae to grow until L4 stage. At 
the first adult day worms were transferred to NGM-
plates containing IPTG seeded with siRNAi producing 
bacteria. After 4 days of feeding, worms were washed 
from NGM plate using M9 buffer. Worms were set on 
ice to assemble on the bottom of the tube. After 
removing the supernatant, the worms were transferred 
to a tube containing beeds (Carl Roth GmbH) for lysis 
(Speed Mill Plus, Analytik Jena) and 2 volumes RIPA 
buffer (150 mM NaCl, 10 nM Tris, pH 7.2, 1% Triton 
X-100, 1% Desoxycholate, 5 mM EDTA) was added to 
the pellet. After lysis samples were centrifuged at 
maximum speed for 5 min (4°C) and supernatant was 
transferred into a fresh tube. Protein concentration was 
determined via BCA-Assay (Thermo Scientific). 10 µg 
of protein from starved mouse liver lysate (C) as 
positive control was used along with 30 µg of protein 
from each lysed worm sample for electrophoresis. 
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Samples were electrophoresed on an 10% SDS-
polyacrylamide gel and electroblotted onto a PVDF 
membrane (Milipore). The membrane was incubated in 
a blocking solution containing anti-phospho-AMPK/ 
anti-AMPK antibody (1:1000dilution; #2535/ #2532, 
Cell Signaling Technology) or anti-tubulin mouse 
antibody (1:1000 dilution; #ab7291, Abcam) at 4°C 
overnight, followed by incubation with anti-mouse or 
anti-rabbit horseradish peroxidase antibody (1:5000 
dilution; #7076/ #7074S Cell Signaling Technology) for 
2 h at 25°C. Stripping Reagent by Roche was used. The 
ECL Western blotting analysis system (Roche) was 
used to detect the secondary antibodies on the 
membrane. Luminescence of the blot was captured 
using Chemidoc imaging system (Bioad).  
 
Oil red O staining. Worms were cultured at 20°C on 
Nematode Growth Medium (NGM) using standard 
methods. Prior to the experiments worms were 
synchronized via 20% Alkaline Hypochlorite Solution 
using standard protocol [32], eggs were transferred to 
new plates for hatching as previously described for life 
span assays. At the L4 (t=0) moult, animals were 
transferred to plates containing ampicillin, FUDR and 
IPTG and stained with Oil Red O after 7 days. For Oil 
Red O staining, animals were washed in M9 buffer, and 
fixed with 4% paraformaldehyde for 15 minutes, were 
washed again and stained in filtered Oil Red O staining 
solution (60% Oil Red O stock solution (5 mg/ml 
isopropanol)/ 40% distilled water) for 30 minutes. After 
washing in M9, worms were analyzed using BZ-II 
Analyzer (KEYENCE, Germany) microscope. 
Photographs of 8-12 worms per condition were taken 
and at 40x magnification at a fixed exposure time. 
 
Statistical analysis. Statistical analyses for Indy/CeNAC2 
knock down and fat content were performed by 
Wilcoxon test. For comparing significant distributions 
between different groups in the life span assays statistical 
calculations were carried out using the log-rank rest 
(Kaplan Meier) as well as the χ2-Test. Given data shows 
mean values ±SEM if not described otherwise. All 
calculations were performed using Microsoft Office 
Excel 2010 and SPSS version 20.0. Experiments were 
performed in triplicate except where stated otherwise. 
Error measures were calculated form the variability of the 
independently prepared biological samples of the same 
treatment group where applicable. Differences were 
considered statistically significant at p < 0.05, therey 
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Table S1e. Life-span No.1 













N2 / empty vector control 16.4 ± 0.28 60  0.027  ≤0.001 
N2 / INDY/CeNAC2 17.2 ± 0.36 60    ≤0.001 
TG38 / empty vector control 13.5 ± 0.26 60   ≤0.001 ≤0.001 
TG38 / INDY/CeNAC2 14.2 ± 0.29 60    ≤0.001 
CB1370 / empty vector control 28.1 ± 1.32 60         
 
 
Table S1f. Life-span No.2 













N2 / empty vector control 15.8 ± 0.29 60  ≤0.001  ≤0.001 
N2 / INDY/CeNAC2 19.3 ± 0.52 60    ≤0.001 
TG38 / empty vector control 14.1 ± 0.21 60   ≤0.001 ≤0.001 
TG38 / INDY/CeNAC2 14.7 ± 0.26 60    ≤0.001 
CB1370 / empty vector control 28.5 ± 1.25 60         
 
 
Table S1g. Life-span No.3 













N2 / empty vector control 15.1 ± 0.28 60  ≤0.001  ≤0.001 
N2 / INDY/CeNAC2 17.8 ± 0.39 60    ≤0.001 
TG38 / empty vector control 15.1 ± 0.26 60   0.131 ≤0.001 
TG38 / INDY/CeNAC2 17.8 ± 0.29 60    ≤0.001 
CB1370 / empty vector control 15.1 ± 0.28 60     
 
 
Table S1h. Life-span No.4 













N2 / empty vector control 14.1 ± 0.27 60  0.001  ≤0.001 
N2 / INDY/CeNAC2 15.9 ± 0.27 60    ≤0.001 
TG38 / empty vector control 15.1 ± 0.46 60   0.597 ≤0.001 
TG38 / INDY/CeNAC2 14.8 ± 0.42 60    ≤0.001 
CB1370 / empty vector control 28.0 ± 1.38 60         
 
Mean  life  span  (±SEM) of worms  fed with E.  coli GC363 harboring  the empty  vector  L4400  (empty  vector  control) 
versus E.coli GC363 harboring the INDY/CeNAC2 RNAi vector and CB1370 daf‐2(e1370) fed with empty vector control. 
N2 wild type worms were used as control. Strain TG38  is short  lived. Strain CB1370 served as  long  lived control. n = 
number of worms used  in  the experiment. Mean  life span and SEM are  in days. Experiments were performed  four 
times with 15 worms per group (total 60). χ2‐Test was performed using IMB SPSS Statistics 20. 
  





































































































Table S2d. Life-span No.1               









DOG - / empty vector control 9.9 ± 0.44 60 0.084 
DOG - / INDY/CeNAC2 11.8 ± 0.57 60 0.401 
DOG + / INDY/CeNAC2 11.6 ± 0.51 60 
DOG + / empty vector control 13.4 ± 0.73 60 0.211 
    
 
Table S2e. Life-span No.2               









DOG - / empty vector control 10.3 ± 0.47 60 0.182 
DOG - / INDY/CeNAC2 12.2 ± 0.62 60 0.882 
DOG + / INDY/CeNAC2 11.7 ± 0.50 60 
DOG + / empty vector control 12.9 ± 0.66 60 0.297 
    
 
Table S2f. Life-span No.3               









DOG - / empty vector control 10.3 ± 0.48 60 0.273 
DOG - / INDY/CeNAC2 12.7 ± 0.66 60 0.614 
DOG + / INDY/CeNAC2 11.6 ± 0.47 60 
DOG + / empty vector control 12.9 ± 0.69 60 0.027 
     
 
Life span represents the mean of four  independent experiments with 15 worms per group (total 60). Mean  life 









































































































Table S3a. Life-span No.1                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
N2 / empty vector control 16,4 ± 0,28 60 17,0 ± 0,36 19,0 ± . 
N2 / ceINDY 17,2 ± 0,36 60 17,0 ± 0,58 21,0 ± . 
TG38 / empty vector control 13,5 ± 0,26 60 14,0 ± 0,39 16,5 ± 0,67 
TG38 / ceINDY 14,2 ± 0,29 60 14,0 ± 0,38 17,5 ± 0,22 
CB1370 / empty vector control 28,1 ± 1,32 60 31,0 ± 2,06   39,5 ± 0,50 
 
Table S3b. Life-span No.2                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
N2 / empty vector control 15,8 ± 0,29 60 16,0 ± 0,42 18,8 ± 0,17 
N2 / ceINDY 19,3 ± 0,52 60 20,0 ± 0,39 24,5 ± 0,22 
TG38 / empty vector control 14,1 ± 0,21 60 14,0 ± 0,24 17,0 ± . 
TG38 / ceINDY 14,7 ± 0,26 60 15,0 ± 0,42 17,7 ± 0,21 
CB1370 / empty vector control 28,5 ± 1,25 60 31,0 ± 2,03   39,3 ± 0,42 
 
Table S3c. Life-span No.3                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
N2 / empty vector control 15,1 ± 0,28 60 15,0 ± 0,51 18,3 ± 0,33 
N2 / ceINDY 17,8 ± 0,39 60 19,0 ± 0,49 21,3 ± 0,33 
TG38 / empty vector control 15,1 ± 0,26 60 14,0 ± 0,39 17,5 ± 0,34 
TG38 / ceINDY 17,8 ± 0,29 60 14,0 ± 0,38 17,3 ± 0,33 
CB1370 / empty vector control 28,0 ± 1,32 60 31,0 ± 2,14   39,7 ± 0,33 
 
Table S3d. Life-span No.4                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
N2 / empty vector control 14,1 ± 0,27 60 14,0 ± 0,24 17,7 ± 0,42 
N2 / ceINDY 15,9 ± 0,27 60 16,0 ± 0,48 18,8 ± 0,31 
TG38 / empty vector control 15,1 ± 0,46 60 16,0 ± 0,79 19,3 ± 0,21 
TG38 / ceINDY 14,8 ± 0,42 60 15,0 ± 0,70 19,3 ± 0,33 














































































































Table S4a. Life-span No.1                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
DOG - / empty vector control 9,9 ± 0,44 60 9,0 ± 0,26 15,7 ± 0,61 
DOG - / ceINDY 11,8 ± 0,57 60 11,0 ± 0,55 18,0 ± 0,73 
DOG + / ceINDY 11,6 ± 0,51 60 11,0 ± 0,32 18,0 ± 0,45 
DOG + / empty vector control 13,4 ± 0,73 60 14,0 ± 1,29 17,7 ± 0,56 
 
Table S4b. Life-span No.2                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
DOG - / empty vector control 10,3 ± 0,47 60 9,0 ± 0,29 15,7 ± 0,61 
DOG - / ceINDY 12,2 ± 0,62 60 11,0 ± 0,51 19,0 ± 0,37 
DOG + / ceINDY 11,7 ± 0,50 60 11,0 ± 0,36 17,8 ± 0,48 
DOG + / empty vector control 12,9 ± 0,66 60 14,0 ± 1,42 17,2 ± 0,48 
 
Table S4c. Life-span No.3                       
strain mean ± SEM n median ± SEM   
maximum 
life span ± SEM 
DOG - / empty vector control 10,3 ± 0,48 60 9,0 ± 0,31 15,7 ± 0,61 
DOG - / ceINDY 12,7 ± 0,66 60 11,0 ± 0,63 18,7 ± 0,21 
DOG + / ceINDY 11,6 ± 0,47 60 11,0 ± 0,36 17,3 ± 0,33 
DOG + / empty vector control 12,9 ± 0,69 60 14,0 ± 1,43 17,5 ± 0,56 
 
Mean, median and maximum life span in days ± SEM of nematodes fed with E. coli GC363 harboring the empty 
vector  L4400  (empty  vector  control)  versus  E.  coli GC363  harboring  INDY/CeNAC2‐  siRNA when  treated with 
DOG. Experiments were performed 4 times with 15 worms per group (total 60). 
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Table S5. Percent median and maximum life span compared to controls 
 
  % mean ± SEM  % median ± SEM   % max  ± SEM 
N2 / empty vector control 100 100 100 
N2 / ceINDY 14,34 ± 3,65 16,49 ± 6,14 15,90 ± 5,14 
TG38 / empty vector control 100 100 100 
TG38 / ceINDY 8,32 ± 3,16 3,57 ± 2,06 2,26 ± 1,15 
Percent median and maximum life span compared to controls (±SEM) under DOG treatment, n=60. Maximum 





mean ± SEM  % median ± SEM   
% 
max  ± SEM 
DOG - / empty vector control 100 100 100 
DOG - / ceINDY 20,12 ± 1,28 22,22 ± 0,00 18,44 ± 1,63 
DOG + / empty vector control 100 100 100 
DOG + / ceINDY -10,99 ± 1,06 -21,43 ± 0,00 1,61 ± 1,22 
Percent median and maximum life span compared to controls (±SEM) under DOG treatment, n=60. 
Maximum life span is the mean life span of the most long-lived 10%; n=6  
